Drug-Target Information
Drug Name Target Name Drug Type Target Type Source Drug MeSHID Interaction Score Drug Status Target Action
siltuximab interleukin-6 biotech Successful target TTD , drugbank , DGIDB Multi-centric Castleman's Disease[MeSHID:C537372]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Disease[MeSHID:D004194]		 10.18 approved,investigational antagonist,antibody
siltuximab interleukin-6 biotech Successful target TTD , drugbank , DGIDB Multi-centric Castleman's Disease[MeSHID:C537372]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
Anemia[MeSHID:D000740]		 10.18 approved,investigational antagonist,antibody
siltuximab interleukin-6 biotech Successful target TTD , drugbank , DGIDB Multi-centric Castleman's Disease[MeSHID:C537372]
Coronavirus Infections[MeSHID:D018352]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Disease[MeSHID:D004194]		 10.18 approved,investigational antagonist,antibody,inhibitor
siltuximab interleukin-6 biotech Successful target TTD , drugbank , DGIDB Multi-centric Castleman's Disease[MeSHID:C537372]
Disruptive
Impulse Control
and Conduct Disorders[MeSHID:D007174]
Multiple Myeloma[MeSHID:D009101]
Anemia[MeSHID:D000740]		 10.18 approved,investigational antagonist,antibody,inhibitor
click here to return to the previous page